在急性肝衰竭中,严重的带有机械通风的肝脑病变可能会告知等候名单优先:UNOS数据库分析:
Jiayi Ma1, James E Slaven2, Lauren Nephew1
1Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Clinical transplantation
|December 2, 2023
概括
急性肝衰竭 (ALF) 患者的器官衰竭显著增加了等候名单和移植后死亡风险. 神经和呼吸系统衰竭是最具影响力的,这表明需要优先考虑风险的器官分配.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 移植医学 移植医学
- 关键护理医学 关键护理医学
背景情况:
- 等待肝移植 (LT) 的急性肝衰竭 (ALF) 患者经常发展多器官衰竭.
- 目前的等候名单优先级不考虑器官衰竭的严重程度.
- 这项研究调查了器官衰竭对ALF患者死亡风险和LT后结果的影响.
研究的目的:
- 检查器官衰竭对ALF患者等候名单死亡风险的影响.
- 评估器官衰竭对LT后结果的影响.
- 为了确定与等候名单死亡率最相关的特定器官衰竭.
主要方法:
- 在UNOS数据库 (2002-2019) 中等候名单上的3212名成年ALF患者的分析.
- 使用修改后序列器官衰竭评分进行器官衰竭评估.
- 对于等待名单和后LT死亡率的回归分析;用于识别有影响力的器官衰竭的隐性类分析 (LCA).
主要成果:
- 有≥3个器官衰竭增加了等候名单死亡风险 (SHR 2.7) 和后LT死亡风险 (HR 1.5).
- 神经和呼吸系统衰竭与30天等候名单死亡率最强烈相关.
- 这些失败也与较低的自发存活或LT删除率相关.
结论:
- 累积器官衰竭,特别是神经和呼吸系统衰竭,对ALF患者的死亡率产生重大影响.
- 研究结果支持将器官衰竭负担纳入风险优先器官分配策略.
- 这种方法可以改善等待肝移植的ALF患者的结果.
相关概念视频
Esophageal Varices-II: Clinical Features and Management
72
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
72
Acute Respiratory Failure-V
142
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
142
Acute Respiratory Failure-III
187
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
187
Acute Respiratory Failure-II
241
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
241


